Nuria Vilarrasa
Overview
Explore the profile of Nuria Vilarrasa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
1288
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ballesteros-Pomar M, Rodriguez-Urgelles E, Sastre-Belio M, Martin-Lorenzo A, Schnecke V, Segu L, et al.
Adv Ther
. 2025 Jan;
42(2):1265-1282.
PMID: 39825974
Introduction: Obesity and its complications are associated with high morbidity/mortality and a significant healthcare cost burden in Spain. It is therefore essential to know the potential clinical and economic benefits...
2.
Miralles-Lluma L, Vilarrasa N, Monasterio C, Lopez-Padros C, Alves C, Planas R, et al.
Nutrients
. 2025 Jan;
16(24.
PMID: 39770877
Studies focusing on the effects of lifestyle strategies on patients with obstructive sleep apnea (OSA) that go beyond body weight and explore body composition are currently scarce and inconclusive. The...
3.
Valdecantos M, Ruiz L, Folgueira C, Rada P, Gomez-Santos B, Solas M, et al.
Nat Commun
. 2024 Nov;
15(1):10342.
PMID: 39609390
Bariatric surgery is effective for the treatment and remission of obesity and type 2 diabetes, but pharmacological approaches which exert similar metabolic adaptations are needed to avoid post-surgical complications. Here...
4.
Gomez-Vaquero C, Picazo M, Humbert L, Hernandez-Montoliu L, Jermakova O, Huanuco L, et al.
Bone
. 2024 Oct;
190:117270.
PMID: 39368725
We evaluated the impact of bariatric surgery on bone mineral density (BMD) and microarchitecture over one year using dual-energy X-ray absorptiometry (DXA), the trabecular bone score (TBS), and 3D-DXA to...
5.
Guerrero-Perez F, Perez Prieto M, Vilarrasa N
Med Clin (Barc)
. 2024 Jul;
163(9):476-477.
PMID: 39030121
No abstract available.
6.
Marques-Pamies M, Gil J, Sampedro-Nunez M, Valassi E, Biagetti B, Gimenez-Palop O, et al.
J Clin Endocrinol Metab
. 2024 Jun;
110(1):30-40.
PMID: 38943661
Context: Medical treatment of acromegaly is currently performed through a trial-and-error approach using first-generation somatostatin receptor ligands (fgSRLs) as first-line drugs, with an effectiveness of about 50%, and subsequent drugs...
7.
Osorio J, Admella V, Merino D, Sobrino L, Tuero C, Vilarrasa N, et al.
Obes Surg
. 2024 May;
34(7):2293-2302.
PMID: 38758514
Introduction: One Anastomosis Duodenal Switch (OADS/SADI-S) is used both as a one stage and a second-step procedure, either planned or revisional after a failed sleeve gastrectomy. However, there is lack...
8.
Vilarrasa N, Salvador J, Poyato F, Rubio-Herrera M
Obes Facts
. 2024 Mar;
17(3):264-273.
PMID: 38493779
Introduction: The differences in the prevalence of obesity between the various regions of Spain, partly attributed to socioeconomic differences, may influence the approach to this disease. The aim of this...
9.
Marques-Pamies M, Gil J, Valassi E, Hernandez M, Biagetti B, Gimenez-Palop O, et al.
Front Endocrinol (Lausanne)
. 2023 Nov;
14:1269787.
PMID: 38027102
Introduction: We previously described that a short version of the acute octreotide test (sAOT) can predict the response to first-generation somatostatin receptor ligands (SRLs) in patients with acromegaly. We have...
10.
Hernandez-Montoliu L, Rodriguez-Pena M, Puig R, Astiarraga B, Guerrero-Perez F, Virgili N, et al.
Front Endocrinol (Lausanne)
. 2023 Nov;
14:1181744.
PMID: 37916149
Objective: To determine changes in incretins, systemic inflammation, intestinal permeability and microbiome modifications 12 months after metabolic RYGB (mRYGB) in patients with type 2 diabetes (T2D) and their relationship with...